bisbenzimidazole has been researched along with Carcinoma, Transitional Cell in 1 studies
Bisbenzimidazole: A benzimidazole antifilarial agent; it is fluorescent when it binds to certain nucleotides in DNA, thus providing a tool for the study of DNA replication; it also interferes with mitosis.
Carcinoma, Transitional Cell: A malignant neoplasm derived from TRANSITIONAL EPITHELIAL CELLS, occurring chiefly in the URINARY BLADDER; URETERS; or RENAL PELVIS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gromova, I | 1 |
| Gromov, P | 1 |
| Celis, JE | 1 |
1 other study available for bisbenzimidazole and Carcinoma, Transitional Cell
| Article | Year |
|---|---|
Identification of true differentially expressed mRNAs in a pair of human bladder transitional cell carcinomas using an improved differential display procedure.
Topics: Bisbenzimidazole; Carcinoma, Transitional Cell; Cloning, Molecular; DNA, Complementary; Electrophore | 1999 |